Navigation Links
Collaboration between Sanofi and Joslin Diabetes Center to focus on new drugs for diabetes
Date:6/19/2012

s risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such product candidates, the absence of guarantee that the product candidates if approved will be commercially successful, the future approval and commercial success of therapeutic alternatives, the Group's ability to benefit from external growth opportunities, trends in exchange rates and prevailing interest rates, the impact of cost containment policies and subsequent changes thereto, the average number of shares outstanding as well as those discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in Sanofi's annual report on Form 20-F for the year ended December 31, 2011. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.Contacts:Sanofi Corporate Media Relations 

 Sanofi Investor RelationsMarisol Peron

 Sebastien MartelTel: +33 (0)1 53 77 45 02

 Tel. : +33 (0)1 53 77 45 45Mobile: +33 (0)6 08 18 94 78

 E-mail: ir@sanofi.comE-mail:

SOURCE Sanofi
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. RayBiotech, Inc. and the University of Oslo Enter into Antibody Array Services Collaboration
2. Big Pharma and Universities Increasingly Work to Advance Life Science Knowledge by Forming Strategic Partnerships, Public-Private Partnerships, and Open Innovation Programs: Pharmaceutical Research Collaborations Summit
3. Trovagene and Strand Life Sciences Plan Collaboration to Validate and Offer Urine-Based HPV Screening Test in India and South Asia
4. Daiichi Sankyo And Coherus BioSciences Establish Strategic Collaboration To Develop And Commercialize Biosimilar Candidates
5. Butamax™ and Fagen Announce Collaboration to Retrofit Ethanol Plants for Biobutanol Production
6. Medivir Announces TMC435 in an Expanded Clinical Collaboration
7. Intellect Neurosciences Enters Collaboration Agreement with Leading Alzheimers Research Group at University of California Irvine to Test First in Class Dual Target Vaccine
8. Aviir Diagnostics Laboratory in Collaboration with Cause;ology Sponsors "Storyland," a Red Carpet Charity Extravaganza in Hollywood
9. Apexigen and Shanghai Duyiwei Biotechnology Co. Ltd Sign a License and Collaboration Agreement to Develop and Commercialize APX004
10. Volition Signs Collaboration Agreement With Abcodia
11. BioCrossroads Commemorates Decade of Collaboration, Success for Indiana Life Sciences Sector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Fla. , Sept. 30, 2014 CORD:USE ... pleased to announce that it has entered into an ... Inc. (Tianhe) which has licensed a series of patented technologies ... cells for possible clinical applications.  Tianhe is performing Phase ... and Spain using Tianhe,s Stem ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 ... solutions for drug discovery and related life ... consortium has chosen Genedata Selector as its ... (NGS) data. FUNGITECT is a European consortium ... fungal diseases via individualized anti-fungal drug therapies. ...
(Date:9/30/2014)... Iowa , Sept. 30, 2014  KemPharm, ... the discovery and development of proprietary new molecular ... States Patent and Trademark Office (USPTO) issued U.S. ... application entitled, "Benzoic Acid, Benzoic Acid Derivatives and ... of Making and Use Thereof." The ...
(Date:9/30/2014)... 2014 FemCap Inc., www.femcap.com  an innovator ... of a patent No: US, 8,795,248 B2 dated Aug. ... FDA clearance in the U.S., 510(K) K121857, medical device ... patent is related to its menstrual cup with a ... is releasing FemmyCycle Teen, a third menstrual cup to ...
Breaking Biology Technology:CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 2CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 3CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 4FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 3KemPharm, Inc. Receives Patent from the USPTO for Novel Prodrug of Hydromorphone, KP511 2The FemmyCycle 2
... and TOKYO, May 7, 2012  Coherus BioSciences, Inc ... (hereafter, Daiichi Sankyo; TSE 4568) announced today the ... commercialize biosimilar forms of etanercept and rituximab in ... http://photos.prnewswire.com/prnh/20120507/SF01448LOGO ) Under the terms ...
... 7, 2012 VWR Funding, Inc., the parent company of ... company, will hold a conference call on Thursday, May 10, ... M. Ballbach , Chairman, President and CEOGregory L. Cowan , ... AM Eastern Time (ET)How:     ...
... RICHLAND, Wash. Creators of a nanotech-based system that ... submarine, while providing a more environmentally friendly removal process, ... for 2012. The technology Self Assembled Monolayers on ... into future submarines to improve air quality for sailors ...
Cached Biology Technology:Daiichi Sankyo And Coherus BioSciences Establish Strategic Collaboration To Develop And Commercialize Biosimilar Candidates 2VWR to Hold First Quarter 2012 Financial Results Conference Call 2Clearing the air: PNNL technology wins award for improving submarine air quality 2
(Date:9/30/2014)... German . FRANKFURT. ... in the world. Because they grow underground, people use trained ... of truffles is not only of interest to gourmets. A ... the Goethe University Frankfurt have discovered that the smell of ... trapped inside truffle fruiting bodies. , White truffles from the ...
(Date:9/30/2014)... Having trouble getting pregnanteven with IVF? Here,s some hope: ... of The FASEB Journal , explains ... protein known as PAWP, which induced embryo development in ... of embryo development by the sperm cell during fertilization. ... represent a major paradigm shift in our understanding of ...
(Date:9/30/2014)... KONG , Sept. 30, 2014 Winners of ... Economist Events, Innovation Summit scheduled to take place at the JW ... the summit, the award winners will share their experiences and the ... who have made a proven innovation over the past decade, will ... the night before the summit. It will be the first ...
Breaking Biology News(10 mins):On the trail of the truffle flavor 2Synthetic sperm protein raises the chance for successful in vitro fertilization 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 3Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 4Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 5Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 6Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 7
... was to test a computer algorithms ability to identify ... classify them according to different contexts and individual dogs. ... Hungarian sheepdogs (Mudi breed) in six different situations: stranger, ... recorded with a tape recorder before being transferred to ...
... The juries of the BBVA Foundation Awards for Biodiversity ... edition of the scheme. The Award for Scientific Research ... been granted ex aequo to leading scientists Harold Mooney ... Conservation projects in Latin America, with prize money of ...
... Isochronous Capability Enhances Company,s Leadership in USB Networking ... ... Silex Technology today,announced the SX-2000WG+ USB device server with isochronous ... like,webcams and speakers to be easily shared among multiple Windows and,Macintosh ...
Cached Biology News:Harold Mooney and Peter Raven, winners of the BBVA Foundation Award for Conservation Biology 2Harold Mooney and Peter Raven, winners of the BBVA Foundation Award for Conservation Biology 3Harold Mooney and Peter Raven, winners of the BBVA Foundation Award for Conservation Biology 4Harold Mooney and Peter Raven, winners of the BBVA Foundation Award for Conservation Biology 5Silex Introduces World's First Wireless USB Device Server With Streaming Video and Audio Data Transfer 2
Mouse monoclonal [6G11] to Cytohesin 1 + 2 ( Abpromise for all tested applications)....
HP 1 alpha Immunogen: Synthetic peptide between amino acids 1-100 of the human HP 1 alpha protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
... KLH-conjugated, synthetic peptide corresponding ... of mouse p19ARF. The ... acids 62-75. Clone 5-C3-1. ... by immunoblot. Stability ...
Request Info...
Biology Products: